The CMS Oncology Care Model (OCM) was associated with reduced chemotherapy initiation and lower Medicare spending among ...
A JAMA Internal Medicine study found the CMS Oncology Care Model reduced chemotherapy initiation and Medicare spending in poor-prognosis cancers. The model showed a 1.5 percentage point drop in ...
Serial metastasis-directed radiotherapy extended time off systemic therapy while maintaining favorable progression-free and overall survival in patients with oligometastatic clear-cell renal cell ...
—Building off of earlier findings, researchers sought to determine rates of neoadjuvant systemic therapy (NST) among U.S. women with cT1–2 N0 M0 HER2-positive breast cancer and identify factors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results